Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TOR Serine-Threonine Kinases”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)UnknownNCT01960829
What this trial is testing

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Who this might be right for
MelanomaTOR Serine-Threonine KinasesNeoplasm Metastasis
Peking University Cancer Hospital & Institute 60
Early research (Phase 1)Study completedNCT00574366
What this trial is testing

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 14
Early research (Phase 1)Study completedNCT00731263
What this trial is testing

Tor Kinase Inhibitor in Advanced Tumors

Who this might be right for
Solid Tumors
AstraZeneca 64
Post-approval studies (Phase 4)Ended earlyNCT01561404
What this trial is testing

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

Who this might be right for
Disorder Related to Renal TransplantationExercise, AerobicMuscle Strength
Josep M Cruzado 3
Large-scale testing (Phase 3)UnknownNCT02055079
What this trial is testing

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Medical University of Vienna 68
Large-scale testing (Phase 3)Study completedNCT01811667
What this trial is testing

Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations

Who this might be right for
Cardiovascular Abnormalities
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 19
Testing effectiveness (Phase 2)Study completedNCT00411619
What this trial is testing

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Children's Hospital Medical Center, Cincinnati 28
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)WithdrawnNCT01188889
What this trial is testing

RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center
Post-approval studies (Phase 4)Study completedNCT01935128
What this trial is testing

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Who this might be right for
Renal Transplant
University of Toledo Health Science Campus 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT05103358
What this trial is testing

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Who this might be right for
TumorTumor, SolidMetastasis+18 more
Aadi Bioscience, Inc. 120
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05285878
What this trial is testing

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more
The Methodist Hospital Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT02093598
What this trial is testing

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus

Who this might be right for
Carcinoma, EndometrioidmTOR Protein
MedSIR 10
Post-approval studies (Phase 4)UnknownNCT03781050
What this trial is testing

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Who this might be right for
Peutz-Jeghers Syndrome
Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)UnknownNCT02730923
What this trial is testing

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

Who this might be right for
Endometrial CarcinomaMetastatic CarcinomaHormone Receptor Positive Tumor
Centre Leon Berard 72
Not applicableUnknownNCT03486366
What this trial is testing

Application of Novel Diagnostic and Therapeutical Methods in Epilepsy and Neurodevelopmental Abnormalities in Children.

Who this might be right for
Epilepsy
Medical University of Warsaw 120
Testing effectiveness (Phase 2)Ended earlyNCT00877773
What this trial is testing

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 44
Testing effectiveness (Phase 2)UnknownNCT02279758
What this trial is testing

A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors

Who this might be right for
Well-differentiated Neuroendocrine Tumors
Instituto do Cancer do Estado de São Paulo 30
Early research (Phase 1)Study completedNCT01548807
What this trial is testing

Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

Who this might be right for
Prostate Cancer Patients With Detectable PSA Following Prostatectomy
Abramson Cancer Center at Penn Medicine 19
Testing effectiveness (Phase 2)Study completedNCT01298713
What this trial is testing

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Who this might be right for
Breast NeoplasmsmTor Protein
ARCAGY/ GINECO GROUP 111
Next Page